Prognostication of recovery in patients with acute ischemic stroke through the use of brain SPECT with technetium-99m - Labeled metronidazole

Stroke

Volumn 34, Issue 4, 2003, Pages 982-986

  Song, Ho Chun ^a   Bom, Hee Seung ^a   Cho, Ki Hyun ^a   Kim, Byeong Chae ^a   Seo, Jeong Jin ^a   Kim, Chang Guhn ^b   Yang, David J ^c   Kim, E Edmund ^c  

^a Chonnam National University Medical School   (South Korea)

^b Wonkwang University Hospital   (South Korea)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cerebral infarction; Metronidazole; Prognosis; Technetium compounds; Tomography, emission computed

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; METRONIDAZOLE TC 99M; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN HYPOXIA; BRAIN INFARCTION; CALCULATION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; EVALUATION; FEMALE; HOSPITAL ADMISSION; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; BRAIN; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CYSTEINE; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; NERVOUS SYSTEM DISEASES; ORGANOTECHNETIUM COMPOUNDS; PROGNOSIS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0037383530     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000062902.94892.F5     Document Type: Article

References (22)

1. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke. 1981;12:723-725.
2. Heiss WD. Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab. 2000;20:1276-1293.
3. Nunn A, Linder K, Strauss HW. Nitroimidazoles and imaging hypoxia. Eur J Nucl Med. 1995;22:265-280.
4. Read SJ, Hirano T, Abbott DF, Sachinidis JI, Tochon-Danguy HJ, Chan JG, et al. Identifying hypoxic tissue after acute ischemic stroke using PET and F-fluoromisonidazole. Neurology. 1998;51:1617-1621.
5. Read SJ, Hirano T, Abbott DF, Markus R, Sachinidis JI, Tochon-Danguy HJ, et al. The fate of hypoxic tissue on F-fluoromisonidazole positron emission tomography after ischemic stroke. Ann Neurol. 2000;48:228-235.
6. 99mTc-labeled metronidazole. Pharm Res. 1999;16:743-750.
7. 99mTc-HMPAO Brain SPECT. Korean J Nucl Med. 1999;33:247-261.
8. Goldstein LB, Bertels C, Davis JN. Interrater reliability of the NIH Stroke Scale. Arch Neurol. 1989;46:660-662.
9. Lythgoe MF, Williams SR, Wiebe LI, McEwan AJ, Gordon I. Autoradiographic imaging of cerebral ischaemia using a combination of blood flow and hypoxic markers in an animal model. Eur J Nucl Med. 1997;24:16-20.
10. Di Rocco RJ, Kuczynski BL, Pirro JP, Bauer A, Linder KE, Ramalingam K, et al. Imaging ischemic tissue at risk of infarction during stroke. J Cereb Blood Flow Metab. 1993;13:755-762.
11. 3H] misonidazole in cerebral ischemia. Stroke. 1987;18:168-176.
12. Jingtao J, Sato S, Yamanaka N. Changes in cerebral blood flow and blood brain barrier in the gerbil hippocampal CA1 region following repeated brief cerebral ischemia. Med Electron Microsc. 1999;32:175-183.
13. 99mTc-HMPAO imaging. Ann Nucl Med. 1995;9:161-166.
14. 133Xe SPECT. J Nucl Med. 2001;42:543-547.
15. Heiss WD, Herholz K. Assessment of pathophysiology of stroke by positron emission tomography. Eur J Nucl Med. 1994;21:455-65.
16. Marchal G, Beaudouin V, Rioux P, de la Sayette V, Le Doze F, Viader F, et al. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. Stroke. 1996;27:599-606.
17. 123I-labeled benzodiazepine receptor antagonist as a predictor of neuronal cell viability: comparisons with 14C-labeled 2-deoxyglucose autoradiography and histopathological examination. Nucl Med Commun. 1995;16:443-446.
18. Toyama H, Matsumura K, Nakashima H, Takeda K, Takeuchi A, Koga S, Yoshida T, Ichise M. Characterization of neuronal damage by iomazenil binding and cerebral blood flow in an ischemic rat model. Ann Nucl Med. 1998;12:267-273.
19. 99 mTc-HMPAO SPECT. J Neurol Neurosurg Psychiatry. 1998;64:90-97.
20. Wei L, Erinjeri JP, Rovainen CM, Woolsey TA. Collateral growth and angiogenesis around cortical stroke. Stroke. 2001;32:2179-2184.
21. Karonen JO, Nuutinen J, Kuikka JT, Vanninen EJ, Vanninen RL, Partanen PL, Vainio PA, Roivainen R, Sivenius J, Aronen HJ. Combined SPECT and diffusion-weighted MRI as a predictor of infarct growth in acute ischemic stroke. J Nucl Med. 2000;41:788-794.
22. Qin Z. A review of therapeutic potentials in ischemic stroke. Eur Neurol. 1998;39(suppl 1):21-25.